Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 3
1994 2
1995 7
1996 3
1997 4
1998 4
1999 2
2000 2
2002 1
2003 8
2004 7
2005 3
2006 5
2007 3
2008 7
2009 6
2010 6
2011 1
2012 7
2013 6
2014 5
2015 6
2016 6
2017 9
2018 10
2019 12
2020 11
2021 12
2022 6
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Can we predict the influence of inflammation on voriconazole exposure? An overview.
Boglione-Kerrien C, Zerrouki S, Le Bot A, Camus C, Marchand T, Bellissant E, Tron C, Verdier MC, Gangneux JP, Lemaitre F. Boglione-Kerrien C, et al. Among authors: tron c. J Antimicrob Chemother. 2023 Nov 6;78(11):2630-2636. doi: 10.1093/jac/dkad293. J Antimicrob Chemother. 2023. PMID: 37796931 Review.
Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting?
Buhl Rasmussen AS, Andersen CL, Weimann A, Yang T, Tron C, Gandemer V, Dalhoff K, Rank CU, Schmiegelow K. Buhl Rasmussen AS, et al. Among authors: tron c. Expert Rev Clin Pharmacol. 2024 Mar;17(3):225-234. doi: 10.1080/17512433.2024.2312256. Epub 2024 Feb 12. Expert Rev Clin Pharmacol. 2024. PMID: 38345044 Review.
[Treatment of intrastent restenosis].
Eltchaninoff H, Tron C, Sebagh L, Cribier A. Eltchaninoff H, et al. Among authors: tron c. Pathol Biol (Paris). 2004 May;52(4):218-22. doi: 10.1016/j.patbio.2004.01.011. Pathol Biol (Paris). 2004. PMID: 15145135 Review. French.
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Feldman D, Cao D, Sartori S, Zhang Z, Hengstenberg C, Tron C, Anthopoulos P, Widder JD, Meneveau N, Stella PR, Ferrari M, Jeger R, Violini R, Dumonteil N, Chen S, Yan R, Nicolas J, Razuk V, Spirito A, Vogel B, Mehran R, Dangas G. Feldman D, et al. Among authors: tron c. Catheter Cardiovasc Interv. 2023 May;101(6):1134-1143. doi: 10.1002/ccd.30647. Epub 2023 Apr 10. Catheter Cardiovasc Interv. 2023. PMID: 37036268 Clinical Trial.
How can we best monitor 5-FU administration to maximize benefit to risk ratio?
Goirand F, Lemaitre F, Launay M, Tron C, Chatelut E, Boyer JC, Bardou M, Schmitt A. Goirand F, et al. Among authors: tron c. Expert Opin Drug Metab Toxicol. 2018 Dec;14(12):1303-1313. doi: 10.1080/17425255.2018.1550484. Epub 2018 Nov 23. Expert Opin Drug Metab Toxicol. 2018. PMID: 30451549 Free article. Review.
162 results